Pohl Boskamp
close
Please enter your login data

In case you forgot your login data, please contact us directly.
Please enter your login data completely!
Login and/or password incorrect!
Login correct, access granted.

Welcome to Pohl Boskamp International - Feel how it works »
kugel-ani.gif
Contact
Pohl Boskamp has been active in the international pharmaceutical market for more than 175 years: According to our motto “Feel how it works!” we make it possible for patients today to experience the immediate effect of our medicinal products and to improve their own quality of life in more than 45 countries. Pohl-Boskamp focus on a trustful cooperation with our partners abroad.

If you have any suggestions to make, or any questions, then please let us know.

G. Pohl-Boskamp GmbH & Co KG
PO Box 1253
25550 Hohenlockstedt, Germany

PHONE: +49 4826 59-0
FAX: +49 4826 59-109 or -169
E-MAIL: contact@pohl-boskamp.com
Core Text
GeloMyrtol® forte – Active ingredient: distillate of a mixture of rectified eucalyptus oil, rectified sweet orange oil, rectified myrtle oil and rectified lemon oil (66:32:1:1) (Myrtol® standardized). Indicated for acute and chronic bronchitis and inflammation of the maxillary sinuses (sinusitis). For information on risks and side effects, read the package leaflet and ask your doctor or pharmacist. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (01/6).

Nitrolingual akut® Spray - Active ingredient: glycerol trinitrate. Composition: 1 metered dose spray contains 0.4 mg glycerol trinitrate. Other ingredients: medium-chain triglycerides and partial glycerides, ethanol, peppermint oil. Indications: prophylaxis and treatment of acute attacks of angina pectoris, acute myocardial infarction, acute left-sided heart failure, catheter-induced coronary spasms. Contraindications: hypersensitivity to any of the ingredients or other nitrate compounds, acute circulatory failure, cardiogenic shock, marked hypotension (syst BP < 90 mmHg), intake of phosphodiesterase inhibitors for the treatment of erectile dysfunction or pulmonary arterial hypertension. Caution in cases of hypertrophic obstructive cardiomyopathy, constrictive pericarditis, pericardial tamponade, low filling pressures (e.g. in cases of acute MI; avoid syst BP < 90 mmHg), aortic and/or mitral valve stenosis, orthostatic circulatory disorders, increased intracranial pressure. During pregnancy and breast-feeding, only after careful consideration whether the benefits outweigh the risks; headache very frequent at the start of treatment, frequent hypotension with reflex tachycardia, drowsiness, dizziness and weakness. Occasional nausea, vomiting, flush, allergic skin reactions, marked decreases in blood pressure with exacerbation of angina pectoris symptoms, bradycardia with fainting. Very rare, exfoliative dermatitis. Development of tolerance and cross tolerance possible, avoid continuous high dosing. Hypoxaemia and ischaemia may occur in CHD. The ability to drive vehicles or operate machines may be impaired, especially in combination with alcohol consumption. PO. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (1).

Nitrolingual infus®. Active ingredient: glycerol trinitrate. Composition: 1 mL infusion solution contains 1 mg glycerol trinitrate. Other ingredients: glucose monohydrate (Ph.Eur.), 10% hydrochloric acid solution (for pH adjustment), water for injections. Indications: severe angina pectoris, acute myocardial infarction, acute left-sided heart failure, hypertensive crisis with acute heart failure, controlled hypotension. Contraindications: hypersensitivity to any of the ingredients or other nitrate compounds, acute circulatory failure, cardiogenic shock, toxic pulmonary oedema, marked hypotension (syst BP < 90 mmHg), disorders with increased intracranial pressure, intake of phosphodiesterase inhibitors for the treatment of erectile dysfunction or pulmonary arterial hypertension. Caution in cases of hypertrophic obstructive cardiomyopathy, constrictive pericarditis, pericardial tamponade, low filling pressures (e.g. in cases of acute MI; avoid syst BP < 90 mmHg), aortic and/or mitral valve stenosis, tendency to orthostatic circulatory disorders, severe liver or kidney disturbances. During pregnancy and breast-feeding, only if prescribed by a physician. Side effects: headache very frequent at the start of treatment; hypotension with reflex tachycardia may occur, Occasional nausea, vomiting, flush, allergic skin reactions, marked decreases in blood pressure with exacerbation of angina pectoris symptoms, bradycardia with fainting. Very rare, exfoliative dermatitis. Development of tolerance and cross tolerance possible, avoid continuous high dosing. Hypoxaemia and ischaemia may occur in CHD. The ability to drive vehicles or operate machines may be impaired, especially in combination with alcohol consumption. PO. G. Pohl-Boskamp GmbH & Co. KG, 25551 Hohenlockstedt, Germany (July 2008).